Caricamento...
Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
Background: Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness of and explore methodological issues for the economic evaluation of biosimila...
Salvato in:
| Pubblicato in: | J Mark Access Health Policy |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Routledge
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144192/ https://ncbi.nlm.nih.gov/pubmed/32284827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2020.1739509 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|